Back to
FRANKLIN TEMPLETON INC
AVLN1 quarters
Position history for
FRANKLIN TEMPLETON INC's holdings in AVALYN PHARMA INC
Yes. Franklin Templeton holds 331,684 shares of AVLN (Avalyn Pharma), worth $10.9M, as of its Q2 2026 13F filing.
Current Value
$10.9M
Current Shares
331,684
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of AVLN: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., CITADEL ADVISORS LLC